Because it hasn't been released as an ASX announcement (LINK), seems to have been released as a worldwide media news release (LINK). Not sure why, would have thought an ASX/US price sensitive announcement with a media release at the same time was the way to go. Anyway, I guess the people responsible know what they're doing.
Also, noted this in the news release:
"HEMGENIX is still currently under assessment by other regulatory agencies."
I'm assuming this means other countries, so more to come in the way of revenue.
And:
LINK
News: CSL CSL Behring Will Begin Commercializing Hemgenix Immediately In The U.S. With A List Price..., page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$255.31 |
Change
-2.070(0.80%) |
Mkt cap ! $123.6B | |||
| Open | High | Low | Value | Volume |
| $256.32 | $256.50 | $252.60 | $171.9M | 674.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6 | $255.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $255.83 | 104 | 1 |
View Market Depth
| Last trade - 16.14pm 21/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |